Press release
Lantheus Holdings, Inc. (NASDAQ: LNTH) Investor Alert: Deadline in Lawsuit on November 10, 2025
A Deadline is coming up on November 10, 2025 in the lawsuit for certain investors in Lantheus Holdings, Inc. (NASDAQ: LNTH).
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and there are strict and short deadlines running. Deadline: November 10, 2025. Lantheus Holdings, Inc. (NASDAQ: LNTH) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Lantheus Holdings, Inc. (NASDAQ: LNTH) common shares between February 26, 2025 and August 5, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 26, 2025 and August 5, 2025, the Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Pylarify's competitive position; notably, that Lantheus was not equipped to properly assess the pricing and competitive dynamics for Pylarify; the Company failed to properly disclose that its early 2025 price increase, issued despite price erosion the year prior, created an opportunity for competitive pricing to flourish, risking Pylarify's price point, revenue, and overall growth potential.
Those who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lantheus Holdings, Inc. (NASDAQ: LNTH) Investor Alert: Deadline in Lawsuit on November 10, 2025 here
News-ID: 4256002 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of CarMax, Inc. (NYSE: KMX) …
An investor, who purchased shares of CarMax, Inc. (NYSE: KMX), filed a lawsuit over alleged violations of Federal Securities Laws by CarMax, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of CarMax, Inc. (NYSE: KMX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 2, 2026. NYSE: KMX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with shares of Synopsys, Inc. (NASDAQ …
An investor, who purchased shares of Synopsys, Inc. (NASDAQ: SNPS), filed a lawsuit over alleged violations of Federal Securities Laws by Synopsys, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Synopsys, Inc. (NASDAQ: SNPS) have certain options and for certain investors are short and strict deadlines running. Deadline: December 30, 2025. NASDAQ: SNPS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investigation announced for Long-Term Investors in shares of Dow Inc. (NYSE: DOW …
An investigation was announced for current long-term investors in shares of Dow Inc. (NYSE: DOW) concerning potential breaches of fiduciary duties by certain directors of Dow Inc.
Investors who are current long term investors in Dow Inc. (NYSE: DOW) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: DOW…
Lawsuit Alert: Investors who lost money with shares of Avantor, Inc. (NYSE: AVTR …
An investor, who purchased shares of Avantor, Inc. (NYSE: AVTR), filed a lawsuit over alleged violations of Federal Securities Laws by Avantor, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Avantor, Inc. (NYSE: AVTR) have certain options and for certain investors are short and strict deadlines running. Deadline: December 29, 2025. NYSE: AVTR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
More Releases for Lantheus
Theranostics Market Is Booming Worldwide with Bayer, Curium, Lantheus
Theranostics Market latest research report added by USD Analytics. The Theranostics Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in the future. The detailed…
Bio-imaging Technologies Market to Show Incredible Growth by 2028 | Bayer, Lanth …
This Bio-imaging Technologies market research performs systematic analysis of the market to provide profound perceptions, determine market situation and potent advancements and track prior market performances. There were several industries got shutdown due to the COVID-19 plague. This market report captures the considerable losses that businesses got and even guides them how to come out of this pandemic situation. As this pandemic left several adverse effects on different business sectors,…
Therapeutic Radiopharmaceuticals Market SWOT Analysis by Key Players- Bayer, Nov …
Worldwide Therapeutic Radiopharmaceuticals Market In-depth Research Report 2021, Forecast to 2026 is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Worldwide Therapeutic Radiopharmaceuticals Market. Some of the key players profiled in the study are Bayer, Novartis,…
Radiopharmaceuticals Market Comprehensive study by Key Players Mallinckrodt, Nor …
Radiopharmaceuticals Market: 2020-2026
A new market study, titled “Radiopharmaceuticals Market by Latest Trends, Growth Drivers and Challenges” has been featured on HTF Market Intelligence. The study evaluates the slowdown in production lines and supply chain and its impact on global marketplace of Radiopharmaceuticals. Players such as Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma & Eli Lilly have additionally given the…
Radiopharmaceutical Market to Witness Growth Acceleration during 2015-2025 - Bay …
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases…
Nuclear Medicine Market Outlook to 2023 | Bracco Imaging, Lantheus Holding, Curi …
The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America…
